{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a mitochondrial Ser/Thr protein kinase.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of cultured SN dopaminergic neurons prepared from PINK1 knockout mice was performed to investigate physiological importance of PINK1 in maintaining mitochondrial membrane potential (ΔΨm) and mitochondrial morphology and test the hypothesis that PARK6 mutations cause the loss of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used, which is confocal imaging for assessing mitochondrial membrane potential and morphology, effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes the use of both wild-type and mutant PINK1 in the assays, providing a direct comparison and validation of the assay for this variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "PARK6 mutant (G309D) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The functional assay data directly applies to the interpretation of the G309D variant, showing a loss of function effect.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G309D variant in PINK1 was shown to be defective in maintaining mitochondrial function and inhibiting oxidative stress in dopaminergic neurons, consistent with a pathogenic effect. The strength of evidence is very strong due to the direct demonstration of loss of function in the functional assays used."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": "417"
        },
        "variant_string_id": "PINK1 E417G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a mitochondrial Ser/Thr protein kinase.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of cultured SN dopaminergic neurons prepared from PINK1 knockout mice was performed to investigate physiological importance of PINK1 in maintaining mitochondrial membrane potential (ΔΨm) and mitochondrial morphology and test the hypothesis that PARK6 mutations cause the loss of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used, which is confocal imaging for assessing mitochondrial membrane potential and morphology, effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes the use of both wild-type and mutant PINK1 in the assays, providing a direct comparison and validation of the assay for this variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "PARK6 mutant (E417G) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The functional assay data directly applies to the interpretation of the E417G variant, showing a loss of function effect.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The E417G variant in PINK1 was shown to be defective in maintaining mitochondrial function and inhibiting oxidative stress in dopaminergic neurons, consistent with a pathogenic effect. The strength of evidence is very strong due to the direct demonstration of loss of function in the functional assays used."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "C",
          "alt": "Δ",
          "position": "145"
        },
        "variant_string_id": "PINK1 CΔ145"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a mitochondrial Ser/Thr protein kinase.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of cultured SN dopaminergic neurons prepared from PINK1 knockout mice was performed to investigate physiological importance of PINK1 in maintaining mitochondrial membrane potential (ΔΨm) and mitochondrial morphology and test the hypothesis that PARK6 mutations cause the loss of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used, which is confocal imaging for assessing mitochondrial membrane potential and morphology, effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes the use of both wild-type and mutant PINK1 in the assays, providing a direct comparison and validation of the assay for this variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "PARK6 mutant (CΔ145) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The functional assay data directly applies to the interpretation of the CΔ145 variant, showing a loss of function effect.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The CΔ145 variant in PINK1 was shown to be defective in maintaining mitochondrial function and inhibiting oxidative stress in dopaminergic neurons, consistent with a pathogenic effect. The strength of evidence is very strong due to the direct demonstration of loss of function in the functional assays used."
    }
  ]
}